Sort
15,842 grants matching “pancreatic cancer”
Identifying novel effectors of oncogenic Kras in pancreatic cells via proximity labelling
$50,520Derek Kingman Cheng · State University New York Stony Brook · F30 · FY2020 · CA
Mechanistic study of TCR signaling strength in CD8 T cell differentiation during pathogenesis of T1DM
$50,520Moujtaba Y Kasmani · Medical College Of Wisconsin · F30 · FY2020 · DK
Sulfatase Activated Fluorescent Probes for In Vivo Diagnostic Imaging of Cancer
$50,474Kimberly Elizabeth Beatty · University Of California Berkeley · F32 · FY2010 · CA
Discovery of Novel Therapeutic Strategies for Cancer Immunotherapy
$50,474Xuan Yang · Yale University · F99 · FY2024 · CA
The Role of Guanine Exchange Factors in Pancreatic Ductal Adenocarcinoma (PDAC)
$50,474Sahar Bannoura · Wayne State University · F99 · FY2024 · CA
Radiometal-cyclized Octerotide Derivatives for Oncology
$50,428Heather M Hennkens · University Of Missouri-Columbia · F32 · FY2007 · CA
Early detection of pancreatic cancer in diabetics
$50,409Ru Chen · University Of Washington · R01 · FY2018 · CA
Chemoprevention of Pancreatic Cancer by EGCG
$50,223Rakesh K. Srivastava · University Of Texas Hlth Ctr At Tyler · R01 · FY2009 · CA
Elucidating the role of palladin/alpha-actinin in cell motility and invasion
$50,054Moriah R Beck · Univ Of North Carolina Chapel Hill · F32 · FY2009 · CA
Origin of Pancreatic Ductal Adenocarcinoma
$50,054Janel Lynn Kopp · University Of California, San Diego · F32 · FY2009 · CA
A differentiation-based mechanism limiting pancreatic tumor initiation
$50,016Nathan Michael Krah · University Of Utah · F30 · FY2019 · CA
Augmenting Pancreatic Cancer Immunotherapy via TGFβ Pathway Inhibition
$50,016Daniel R Principe · University Of Illinois At Chicago · F30 · FY2019 · CA
Mechanisms of Escape from TGFβ Tumor Suppression in the Pancreas
$50,016Yun-Han Huang · Weill Medical Coll Of Cornell Univ · F30 · FY2019 · CA
Identifying novel effectors of oncogenic Kras in pancreatic cells via proximity labelling
$50,016Derek Kingman Cheng · State University New York Stony Brook · F30 · FY2019 · CA
Physiological Role of Dynamin-Related Protein 1 in Pancreatic Ductal Adenocarcinoma
$50,016Sarbajeet Nagdas · University Of Virginia · F30 · FY2019 · CA
Long Non-Coding RNA-mediated Differential Regulation of Notch Pathway Targets in Early T-cell Development
$50,016Abhik Banerjee · California Institute Of Technology · F30 · FY2019 · HL
Development of a novel Antibody Drug Conjugate for the treatment of pancreaticcancer
$50,016Christopher Marr Gromisch · Boston University Medical Campus · F30 · FY2019 · CA
The Role of Leukocytes in the Hypothalamus in Cancer Cachexia
$50,016Kevin Glenn Burfeind · Oregon Health & Science University · F30 · FY2019 · CA
I-Corps: Translation Potential of Intratumoral Drug Delivery System
$50,000Carlo G Traverso · Massachusetts Institute Of Technology · · FY2024 · TIP
International Symposium of ALPD and Cirrhosis
$50,000Hidekazu Tsukamoto · University Of Southern California · R13 · FY2018 · AA
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
$50,000Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R41 · FY2017 · CA
Comprehensive Cancer Center Core Support Grant
$50,000Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2009 · CA
Screening for pancreatic cancer via nanocytology of duodenal cells
$50,000Lusik Surenovna Cherkezyan · Nanocytomics, Llc · R43 · FY2018 · CA
Mechanisms of Met Induced Hepatocytes Survival
$50,000Reza Zarnegar · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
I-Corps: Nano Drug Enabled Cancer Therapy
$50,000Nawab Ali · University Of Arkansas Little Rock · · FY2022 · TIP